KNSA

Kiniksa Pharmaceuticals (KNSA) moved up after first-quarter 2026 results showed that ARCALYST remains a stronger commercial asset than many small-cap…

Kiniksa Pharmaceuticals International, plc reported first-quarter results that exceeded Wall Street expectations, with the biopharmaceutical company posting diluted earnings of…

Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) Q4 2021 Earnings Conference

Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) Q3 2021 Earnings Conference

Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) Q2 2021 Earnings Conference